 to continually innovate, which I think if you connect that to the increased transparency of patients could be a catalyst for finally lowering prices. So what can we do at the federal level, not only to prioritize the policies that promote competition in the marketplace, but making sure that those savings, well, make sure that those savings ultimately reach patients? I think number one is to